Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review
Authors:
- A. SquizzatoASA. Squizzato
- M. GalliMGM. Galli
- F. DentaliFDF. Dentali
- W. AgenoWAW. Ageno
Open Access
- 30 April 2009
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 33 (5) , 1148-1155
Abstract
The published literature regarding the safety of outpatient treatment of symptomatic pulmonary embolism (PE) was systematically summarised.A literature search was performed using the PubMed and EMBASE databases. Studies in which patients had symptomatic PE and the antithrombotic treatment was administered completely at home or the patients were discharged early were selected. A scoring system was used to divide studies into three quality categories. Short- and long-term outcomes were extracted: all-cause mortality, death from PE or from major haemorrhage, recurrent venous thromboembolism, and major bleeding.Eleven observational studies were included. No randomised controlled studies were identified. No study fulfilled the criteria for high quality. A total of 928 patients with symptomatic PE were treated completely as outpatients or discharged early; haemodynamic instability and hypoxia were the main exclusion criteria. No patient died during the first 7 days of antithrombotic treatment.Outpatient treatment of symptomatic PE is not based on high-quality evidence. Although the published data suggest that certain subgroups of haemodynamically and respiratorily stable patients may be safely treated at home when a well-defined management programme is applied, further studies are warranted for a short-term prognostic risk stratification of this PE subgroup.Keywords
This publication has 38 references indexed in Scilit:
- Guidelines on the diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2008
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2008
- The MASTER registry on venous thromboembolism: Description of the study cohortThrombosis Research, 2008
- Idraparinux versus Standard Therapy for Venous Thromboembolic DiseaseNew England Journal of Medicine, 2007
- Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and HarmsThe American Journal of Medicine, 2007
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003
- British Thoracic Society guidelines for the management of suspected acute pulmonary embolismThorax, 2003
- Eligibility for Outpatient Treatment With Low-Molecular-Weight Heparin in Venous ThromboembolismArchives of internal medicine (1960), 2000
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996